有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | methyl 2-[[5-[(1S,2S)-2-methyl-1-[(2-methylpropan-2-yl)oxycarbonylamino]butyl]-1,3,4-oxadiazol-2-yl]sulfanyl]acetate | —— | C15H25N3O5S |
|
—— | (3R)-N-methyl-N-[(1S)-1-(4-methylsulfanylphenyl)ethyl]piperidin-3-amine | —— | C15H24N2S |
|
—— | 1-[5-(Methylsulfanyl)-1,3,4-oxadiazol-2-yl]methanamine | —— | C4H7N3OS |
|
—— | Tert-butyl N-{1-[5-(propylsulfanyl)-1,3,4-oxadiazol-2-YL]ethyl}carbamate | —— | C12H21N3O3S |
|
—— | Tert-butyl N-[1-(5-{[(3-bromophenyl)methyl]sulfanyl}-1,3,4-oxadiazol-2-YL)ethyl]carbamate | —— | C16H20BrN3O3S |
|
—— | tert-butyl N-[2-[5-[(3-bromophenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]ethyl]carbamate | —— | C16H20BrN3O3S |
|
—— | methyl 2-[[5-[(1S,2R)-2-methyl-1-[(2-methylpropan-2-yl)oxycarbonylamino]butyl]-1,3,4-oxadiazol-2-yl]sulfanyl]acetate | —— | C15H25N3O5S |
|
—— | tert-butyl N-[2-[5-[(4-bromophenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]ethyl]carbamate | —— | C16H20BrN3O3S |
|
—— | 2-(4-chlorophenyl)sulfanyl-N-[(Z)-(2-fluorophenyl)methylideneamino]acetamide | —— | C15H12ClFN2OS |
|
—— | 2-(4-chlorophenyl)sulfanyl-N-[(Z)-(2,4-difluorophenyl)methylideneamino]acetamide | —— | C15H11ClF2N2OS |
|
—— | 2-(4-chlorophenyl)sulfanyl-N-[(Z)-[4-(dimethylamino)phenyl]methylideneamino]acetamide | —— | C17H18ClN3OS |
|
—— | 2-(4-chlorophenyl)sulfanyl-N-[(Z)-pyridin-2-ylmethylideneamino]acetamide | —— | C14H12ClN3OS |
|
—— | N-[(Z)-butan-2-ylideneamino]-2-(4-chlorophenyl)sulfanylacetamide | —— | C12H15ClN2OS |
|
—— | 3-chloro-2,2-dimethyl-N-[(1R)-1-(4-methylsulfanylphenyl)ethyl]propanamide | —— | C14H20ClNOS |
|
—— | 3-chloro-2,2-dimethyl-N-[(1S)-1-(4-methylsulfanylphenyl)ethyl]propanamide | —— | C14H20ClNOS |
|
—— | (2S)-2-(cyclopropylamino)-2-methyl-6-(2-methylsulfonylethylsulfanyl)hexanenitrile | —— | C13H24N2O2S2 |
|
—— | (2R)-2-(cyclopropylamino)-2-methyl-6-(2-methylsulfonylethylsulfanyl)hexanenitrile | —— | C13H24N2O2S2 |
|
—— | 2-(4-chlorophenyl)sulfanyl-N-[(Z)-[(3S)-3-methylcyclohexylidene]amino]acetamide | —— | C15H19ClN2OS |
|
—— | N-(3-fluorophenyl)-5-(2-piperidin-1-ylethylsulfanyl)-1,3,4-thiadiazol-2-amine | —— | C15H19FN4S2 |
|
—— | (2R)-2-methyl-6-(2-methylsulfonylethylsulfanyl)-2-(propylamino)hexanenitrile | —— | C13H26N2O2S2 |
|
—— | (2R)-2-methyl-4-(2-methylsulfonylethylsulfanyl)-2-(propan-2-ylamino)butanenitrile | —— | C11H22N2O2S2 |
|
—— | 2-[[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-1-[(2R)-2-thiophen-2-ylpyrrolidin-1-yl]ethanone | —— | C18H16FN3O2S2 |
|
—— | (2R)-2-(cyclopropylamino)-2-methyl-5-(2-methylsulfonylethylsulfanyl)pentanenitrile | —— | C12H22N2O2S2 |
|
—— | (2S)-2-(cyclopropylamino)-2-methyl-5-(2-methylsulfonylethylsulfanyl)pentanenitrile | —— | C12H22N2O2S2 |
|
—— | 1-[(3R)-3,5-bis(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-ylsulfanyl)ethanone | —— | C20H21N5O3S |
|
—— | 2-(2-cyanophenyl)sulfanyl-N-[(2R)-2-(dimethylamino)-2-thiophen-2-ylethyl]benzamide | —— | C22H21N3OS2 |
|
—— | Methyl 2-[[4-(4-chlorophenyl)-5-sulfanylidene-1,3,4-thiadiazol-2-yl]sulfanyl]acetate | —— | C11H9ClN2O2S3 |
|
—— | N-[(3S)-1-benzylpyrrolidin-3-yl]-2-phenylsulfanylpyridine-3-carboxamide | —— | C23H23N3OS |
|
—— | 2-[(2R)-1-[(6-methylpyridin-2-yl)methyl]-4-[[5-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]furan-2-yl]methyl]piperazin-2-yl]ethanol | —— | C21H28N6O2S |
|
—— | [(Z)-4-amino-3-cyano-2-oxopent-3-enyl] 4-(4-chlorophenyl)sulfanylbutanoate | —— | C16H17ClN2O3S |
|
—— | (1R)-N-ethyl-1-[2-(2-methylsulfonylethylsulfanyl)phenyl]ethanamine | —— | C13H21NO2S2 |
|
—— | 3-benzylsulfanyl-4-[(1S,2S,4S)-2-bicyclo[2.2.1]hept-5-enyl]-1H-1,2,4-triazol-5-one | —— | C16H17N3OS |
|
—— | (1R)-N-ethyl-1-[4-(2-methylsulfonylethylsulfanyl)phenyl]ethanamine | —— | C13H21NO2S2 |
|
—— | (1S)-N-ethyl-1-[2-(2-methylsulfonylethylsulfanyl)phenyl]ethanamine | —— | C13H21NO2S2 |
|
—— | 3-benzylsulfanyl-4-[(1S,2R,4S)-2-bicyclo[2.2.1]hept-5-enyl]-1H-1,2,4-triazol-5-one | —— | C16H17N3OS |
|
—— | methyl 2,4-dimethyl-5-[2-[(4-phenyl-1,3-thiazol-2-yl)sulfanyl]acetyl]-1H-pyrrole-3-carboxylate | —— | C19H18N2O3S2 |
|
—— | (1R)-1-[4-benzyl-5-[(3,5-dimethylphenyl)methylsulfanyl]-1,2,4-triazol-3-yl]-N,N-dimethylpropan-1-amine | —— | C23H30N4S |
|
—— | (1R)-N-ethyl-1-[2-fluoro-6-(2-methylsulfonylethylsulfanyl)phenyl]ethanamine | —— | C13H20FNO2S2 |
|
—— | (1S)-N-ethyl-1-[2-fluoro-6-(2-methylsulfonylethylsulfanyl)phenyl]ethanamine | —— | C13H20FNO2S2 |
|
—— | 1-(2-Adamantyl)-3-(2-methylprop-2-enyl)thiourea | —— | C15H24N2S |
|
—— | 2-[(2R)-1-[(5-methylfuran-2-yl)methyl]-4-[(2-methylsulfanylpyrimidin-5-yl)methyl]piperazin-2-yl]ethanol | —— | C18H26N4O2S |
|
—— | N-benzyl-2-phenylsulfanyl-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)acetamide | —— | C22H22N2OS2 |
|
—— | N-butyl-2-(3-cyanopyridin-2-yl)sulfanyl-3H-benzimidazole-5-sulfonamide | —— | C17H17N5O2S2 |
|
—— | 2-(4,6-dimethylpyrimidin-2-yl)sulfanyl-1-[(2R)-2-thiophen-2-ylpyrrolidin-1-yl]ethanone | —— | C16H19N3OS2 |
|
—— | 1-[(3R,3aS,7Z)-3-(furan-2-yl)-7-(furan-2-ylmethylidene)-3a,4,5,6-tetrahydro-3H-indazol-2-yl]-2-[[5-(butylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]ethanone | —— | C24H27N5O3S2 |
|
—— | (2R)-N-(3-ethoxypropyl)-2-(2-methylsulfonylethylsulfanyl)propan-1-amine | —— | C11H25NO3S2 |
|
—— | N'-hydroxy-6-(2-methylsulfonylethylsulfanyl)pyridine-3-carboximidamide | —— | C9H13N3O3S2 |
|
—— | (2S)-N-(3-ethoxypropyl)-2-(2-methylsulfonylethylsulfanyl)propan-1-amine | —— | C11H25NO3S2 |
|
—— | N'-hydroxy-2-(2-methylsulfonylethylsulfanyl)benzenecarboximidamide | —— | C10H14N2O3S2 |
|
—— | 3-fluoro-N'-hydroxy-4-(2-methylsulfonylethylsulfanyl)benzenecarboximidamide | —— | C10H13FN2O3S2 |
|